Evidence map›Paper›PMID 41663436›Full record

ArticleNature communications2026

XL-MSDigger: a deep learning-based, versatile solution for cross-linking mass spectrometry.

Moran Chen, Yanhong Hao, Xiao Huang, Pengfei Wu, Jian Sun, Bing Zhang, Suming Chen

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Moran Chen *The Institute for Advanced Studies, Wuhan University, Wuhan, Hubei, China.ORCID 0000-0001-7608-9062
Yanhong Hao *The Institute for Advanced Studies, Wuhan University, Wuhan, Hubei, China.
Xiao HuangThe Institute for Advanced Studies, Wuhan University, Wuhan, Hubei, China.
Pengfei WuThe Institute for Advanced Studies, Wuhan University, Wuhan, Hubei, China.ORCID 0009-0004-9083-5374
Jian SunThe Institute for Advanced Studies, Wuhan University, Wuhan, Hubei, China.
Bing ZhangLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0001-8676-2425
Suming ChenThe Institute for Advanced Studies, Wuhan University, Wuhan, Hubei, China. sm.chen@whu.edu.cn.ORCID 0000-0002-8017-0282

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22074111National Natural Science Foundation of China (National Science Foundation of China) 22474098
6 · The paper itself

Abstract

Cross-linking mass spectrometry (XL-MS) technology plays an important role in protein structure and protein-protein interaction (PPI) studies. However, there are serious shortcomings in the data processing and analysis methods of XL-MS that limit its ability to perform in-depth analysis. Here, we built a deep learning-based XL-MS versatile platform, XL-MSDigger, to address the bottlenecks of XL-MS technology. The foundation of this platform is a deep learning-based multidimensional information prediction tool, Deep4D-XL, for cross-linked peptides. This tool is capable of accurately predicting retention time, collisional cross-section, and fragment ion intensity information of cross-linked peptides. Through the multidimensional information prediction, we develop rescoring algorithms and workflows for DDA and DIA analysis data, which improve the coverage of DDA-based XL-MS identification, and realize the evaluation of false discovery rate and high-reliability identification of DIA-based XL-MS analysis. In addition, XL-MSDigger enables DIA-based XL-MS analysis using predicted spectral libraries, allowing improved detection of protein-protein interactions in targeted or moderate-scale interaction analyses. We believe that the XL-MSDigger platform can be widely used as a general solution to enhance the performance of XL-MS analysis.

Indexed as

Cross-Linking ReagentsDeep LearningMass SpectrometryAlgorithmsPeptidesProtein Interaction MappingProteinsSoftwareCross-Linking ReagentsPeptidesProteins

Identifiers

PMID41663436
PMCPMC12999992

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.